LONDON (Reuters) -Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the drugs watchdog ...

Financial terms of the new agreement include an upfront payment to secure rights to Alchemab's lead ALS candidate, ATLX-1282, ...

PIC's gene-edited pigs are highly resistant to one of the most harmful viruses affecting pig populations worldwide today.

Dr. Binks joins Capricor in anticipation of potential approval of deramiocel in Q3 2025, bringing extensive experience in ...

Combine this with a large increase in funding, and you could start to see the rewards of leading a UK biotech company to success start to become enticing – the $354 million that David Hung ...

The trust’s focus on smaller biotech companies is seen as a strategic advantage, potentially benefiting from the growth in M&A activity. The trust’s shares are reportedly available at a discount of ...

“Your employer hires your insurance company, and so your employer should say to the insurance company, ‘We're going to hold ...

A biotechnology company specialising in pre-clinical testing for fibrotic diseases has been bought by a private equity firm ...

Joint Venture Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter joint venture deals. Fully revised and updated, the report ...

REHOVOT, Israel - Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage biopharmaceutical company with a market capitalization of $6.07 million, today announced the appointment of Shai Lankry as ...

Ventures Tour featuring a range of portfolio pitch sessions hosted by some of Cambridge’s most prominent venture capital ...

Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV ...